NCT03150212 - Effect of Saccharomyces Cerevisiae on the Improvement of Gastro-intestinal Disorders Associated to IBS With C Phenotype | Biotech Hunter

Enrollment

456

Participants

Timeline

Start Date

March 20, 2017

Primary Completion Date

May 9, 2019

Study Completion Date

May 9, 2019

Conditions

Constipation-predominant Irritable Bowel Syndrome

Interventions

DIETARY_SUPPLEMENT

Saccharomyces cerevisiae CNCM I-3856

2 capsules daily, just before the breakfast with a glass of water, during 8 weeks.

DIETARY_SUPPLEMENT

Placebo

2 capsules daily, just before the breakfast with a glass of water, during 8 weeks.

Trial Locations (5)

Biofortis Mérieux NutriSciences, Saint-Herblain

General pratices, France

Eurofins Optimed, Gières

Créabio Rhône Alpes, Givors

Institut Pasteur de Lille, Lille